Regulations for the Notification of Drug Patent Linkage Agreements Article 2

The parties of the agreements as stipulated in Paragraph 1 of Article 48-19 of the Act, shall notify the following items in writing and in Chinese:1. Name, nationality and domicile, place of domicile or business office; for a party of the agreements having a legal representative, the name, place of domicile of the legal representative shall be listed.2. Purpose of the agreement.3. Effective date of the agreement4. The drug permit number or the application number related to the agreement.5. The information regarding the drugs manufacturing, selling, the occurrence day of marketing exclusivity of drug, the marketing exclusivity period and other correlated contents associated with Chapters 4 of the Act.6. Certification numbers of patent related to the content of the agreement.7. Payment interest related matters; if reverse payment interest agreement is involved, shall indicate whether have notified the Fair Trade Commission.The occurrence day stipulated in Item 5 of the preceding Paragraph hereof, shall be based on the effective date of the agreement. But, the application date of filling generic drugs registration shall be deemed as the occurrence day if it is latter than the effective date of the agreement.The notificationThe notification of agreements, as set forth in Paragraph 1, shall notify the Central Competent Health Authority within 20 days after the next day to the occurrence of such matter